In recent years, as the pharmaceutical industry has been expanding, the complexity of drug distribution and the challenges in regulatory oversight have become pronounced. From production to consumption, drugs typically undergo such links as production, warehousing, transportation, wholesale, and retail, involving a vast amount of data and multiple responsible subjects. Once quality issues arise, the traditional regulatory model is often challenged by tracing, accountability, and recalling products due to information gaps and inconsistent standards. In response, Huai'an Municipal Administration for Market Regulation has pioneered the innovation of regulatory modes by employing technologies, such as building an innovative drug supervision system based on blockchain technology. Leveraging the technical characteristics of blockchain, such as decentralization and data immutability, the system tracks the circulation of special drugs. Marking the procurement, sales, and storage processes of drugs on the blockchain makes on-chain data query and visual supervision available. Consequently, it achieves full traceability of the source and destination of the drugs throughout the entire chain, ensuring the security and accuracy of the specific drugs, personnel, and other information in the whole process, multiple links, and the long chain, and offering robust data support for rapid traceability and accountability definition in subsequent regulatory efforts.

In recent years, Huai'an Municipal Administration for Market Regulation has integrated computing power, transferred its whole operations to the cloud, merged various information systems, and established a unified identity authentication system and an integrated information platform for market supervision that encompasses the smart drug supervision system, thereby propelling the digital transformation of both supervision and service. Currently, the platform has recorded the information of 2,675 drug retail enterprises, 4,931 medical device enterprises, and over 7,790 licensed pharmacists across the city. It has enabled real-time and dynamic monitoring of 3,558 batches of 186 types of special drugs, achieving a 100% coverage rate of regulatory targets.